Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA's Orphan Drug Designation Reviews Often Don't Include Regulatory Histories, GAO Says

Dec 03 2018

• By Derrick Gingery

FDA entrance sign 2016

Related Content

FDA's Orphan Designation Backlog Plan Focuses On Efficiency, Not Staff

Jun 29 2017

Are Orphan Incentives Necessary For Development? Sponsors Aren't So Sure

Dec 03 2018

US FDA May Wait Until Late 2019 Before A Cures Hiring Enhancement Is Available

Sep 27 2018

US FDA Appoints Another Orphan Products Development Office Head Amid Growth Expectations

Oct 15 2018

Orphan Designation Requests To Get Slower Reviews

May 11 2016

Additional Topics

United States Rare Diseases Drug Review Regulation FDA BioPharmaceutical

More from Rare Diseases

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window